Oikos and Activia surged with GLP-1 users, but plant upgrades caused disruptions. An EY-Parthenon survey of 3,600 users found 61% eating more protein.
Recap by typeshit. Full story at Food Industry Executive.
Novo reports nine-month results on Nov. 4, after a US judge declined its request to pause Lilly's weight-loss drug ads while the marketing dispute continues.
The Urban Zakapa singer shared gym-bound photos captioned with a call to go work out, as she focuses on exercise to hold her weight after stopping Wegovy.
The fitness creator argues people chase shortcuts and should handle walking, tracking food, water and 7 to 9 hours of sleep before adding peptides.
The Wegovy-sponsored CFL Division Finals kick off November 7 at 3:00 PM ET, the next step on the road to the Grey Cup.
A short medical news share notes that as GLP-1 use spreads, the effects on frail patients are still not well understood.
A post-hoc REDEFINE 1 analysis in 2,309 women showed 25.0% average weight loss on CagriSema at 68 weeks, assuming full adherence. A judge also denied Novo's bid to block Lilly ads.
Loading…